The in vitro susceptibility of 155 strains of anaerobic bacteria to five cephalosporin antibiotics was tested. Cefoxitin was the most active against 33 isolates of Bacteroides fragilis; 82% of the strains were sensitive at 16 jg/ml. At 64 yg/ml cefazolin and cephaloridine were also generally effective. Cephalothin and cephalexin were relatively inactive versus B. fragilis. Cefoxitin, cephaloridine, cefazolin, and cephalothin showed comparable activity against 122 strains of anaerobes other than B. fragilis. More than 90% of the strains were sensitive to each of these antimicrobials at 16 gg/ml. Cephalexin was the least effective cephalosporin against all species tested.
In a recent review of anaerobic bacteria in serious infections in man, it was noted that Bacteroides fragilis occupied a preeminent position because of its frequency of isolation and its resistance to commonly used antimicrobial agents (6) . At present, the armamentarium for treating infections with this organism is limited to clindamycin and chloramphenicol. Serious complications with both of these antimicrobials has led to a search for alternate agents.
Several laboratories have assessed the activity of cephalosporins against B. fragilis. Martin et al. studied 195 strains of B. fragilis and found that only 4% were susceptible to cephalothin at 12.5 ,ug/ml, and 9% were susceptible at the 25 ug/ml level (11) . Kislak, in a study of 40 strains of B. fragilis, showed that cephaloridine had increased activity; however, 50% of the strains were still resistant at 25 ,ug/ml (9) . The clinical significance of these in vitro observations was demonstrated in a double-blind study of antimicrobial treatment in intra-abdominal sepsis following trauma (14) . There was a significant increase in the isolation of anaerobes in patients treated with cephalothin compared to those receiving clindamycin. The increased incidence of septic complications in the cephalothin treated patients was attributed to anaerobic infections, in which B. fragilis was the most common isolate.
Previous reports have suggested that the resistance of B. fragilis to cephalosporin antibiotics is due to the production of cephalosporinase (1, 4) . The development of cephamycin C, which is known to be resistant to certain betalactamases, raised speculation that this agent 128 might have superior activity against B. fragilis (3, 12) . In a limited report, Kosmidis et al. (10) showed that cefoxitin had greater activity than cephalothin against 10 strains of B. fragilis. The purpose of this study was to examine the in vitro antimicrobial activity of cefoxitin against a miscellany of anaerobic bacteria including B. fragilis and to compare the results with four other cephalosporin antibiotics. Procedures. The procedure used for the antimicrobial susceptibility testing was a modified agar dilution method utilizing a Steers replicator (13) . Eight to ten fresh colonies of each isolate were inoculated into prereduced brain heart infusion broth supplemented with yeast extract (0.5%), hemin (0.0005%), and vitamin K, (0.1 ,g/ml; Scott Laboratories, Fiskeville, R.I.). The inoculum was incubated at 37 C; rapid growers were cultured for 5 to 6 h, and slow growers were cultured for 24 h. The agar medium consisted of brain heart infusion base (BBL) with 1.5% agar enriched with 5% laked sheep blood and vitamin K, (10 Ag/ml). The plates were prepared on the morning of the test by adding the blood and serial twofold dilutions of the antibiotic to a final volume of 20 ml; the final mixture was poured into petri dishes (100 by 15 mm). The final concentrations of the antibiotics ranged from 0.125 to 64 sg/ml. After drying in an incubator for 45 min, the plates were transferred into the anaerobic chamber 3 to 4 h prior to inoculating.
MATERIALS AND METHODS
The inoculum was diluted (1:100) to give a concentration of approximately 107 colony-forming units per ml, and the plates were inoculated with approximately 104 colony-forming units per ml in the chamber with a Steers replicator. Anaerobic and aerobic control plates were included for each antimicrobial agent. The plates were incubated for 48 h at 37 C in the anaerobic chamber. The minimal inhibitory concentration was defined as the lowest concentration of antibiotic which showed no growth, a barely visible haze, or a single colony (5) . A control strain of B.
fragilis (Wadsworth Anaerobic Laboratory no. 1887; kindly supplied by V. L. Sutter) was included in each test run.
RESULTS
The in vitro activity of the five antimicrobial agents against 33 strains of B. fragilis demonstrates that cefoxitin is the most active compound ( Fig. 1) . At 16 Ag/ml, 82% of the strains were inhibited, and at 64 yg/ml all but one were inhibited. Cefazolin and cephaloridine possessed similar activity against B. fragilis, although these drugs were generally fourfold less active than cefoxitin. Cephalexin and cephalothin showed the poorest activity; only 27 and 42% of strains were susceptible at 64 ,ug/ml, respectively.
Cefoxitin also demonstrated good activity against anaerobes other than B. fragilis. Except for two strains of fusobacteria all other gram-negative anaerobes were inhibited by 16 ,gg/ml (Table 1) . Among 43 strains of gramnegative cocci 42 were inhibited by 16 ,ug/ml. All ten strains of Eubacterium were inhibited by 16 gg/ml or less. Clostridium perfringens strains were inhibited by 4 ,ug/ml or less, whereas 81% of the other Clostridium species were inhibited by 16 ,ug/ml. Cefoxitin was effective against all clostridia at the 64 Ag/ml level.
With cefazolin, all but one of the gram-negative bacilli other than B. fragilis were inhibited by 16 ug/ml ( Cephalexin showed the poorest activity against the 155 strains (Table 5) . At 16,ug/ml, 37% of the anaerobic cocci, 45% of fusobacteria, and 61% of clostridia were resistant.
The control strain B. fragilis (Wadsworth Anaerobic Laboratory no. 1887) was within the previously performed limits of susceptibility in all the tests (V. L. Sutter, personal communication).
DISCUSSION
The results of this study indicate that of the five cephalosporin antimicrobial agents tested, cefoxitin was the most consistently active against the 155 anaerobic strains. With conventional doses, 16 ,ug/ml was considered the upper limit of the susceptible range, based on readily achievable blood levels (2). Cefoxitin showed greater activity at this level against the 33 strains of B. fragilis as compared to the other agents. Higher doses of cefoxitin, cephalothin, and cefazolin can produce blood levels of 64 Mg/ml (2, 7, 10) . All but one strain of B. fragilis was inhibited by cefoxitin at this level, compared to 90% of strains that were inhibited by cefazolin and less than 50% by cephalothin. activity against the gram-positive anaerobes which was comparable to that of the other cephalosporins. This is in contrast to the activity of this agent against facultative gram-positive organisms, such as the staphylococcus and pneumococcus (15) . The excellent activity of cefoxitin against several species of anaerobic bacteria, including B. fragilis, would suggest that it may be useful in the treatment of anaerobic infections. Cefazolin, at higher dosages, may also be efficacious on the basis of in vitro studies. Alternative drugs for anaerobes would be desirable, and it may be warranted to test these cephalosporin antibiotics in anaerobic infections.
